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Summary: A high performance liquid chromatography (HPLC) with isocratic ion-pair-re versed-phase separation
and simultaneous UV-detection at 232 nm and 292 run is proposed as a method for the simultaneous determination
of uric acid and cratinine in serum. The only sample preparation required is an appropriate dilution with the eluent
and membrane filtration on non-adsorbent 0.2 μτη membrane-filtration-devices.
The inaccuracy of the method has been determined for NIST-SRM-909 (n = 10) and was + 0.5% for creatinine as
well as for uric acid. The imprecision in this case was 0.8% for both analytes. The within-run imprecision for
creatinine/uric acid was 0.4-^0.5%/0.2—0.4% in the case of standards and 0.6—0.8%/0.4-0.7% in the case of
serum-pools. The between-run imprecision for creatinine/uric acid obtained from serum pools was 0.8—1.1 %/
0.7-1.0%.
The results for creatinine have been compared to those from an isotope dilution-gas chromatography-mass spectro-
metry using [13C, 15N2]creatinine as internal standard and selected mass detection at m/e = 329 and m/e = 332.
The results for uric acid have been compared to an HPLC-method published previously (Kock R et al. J Clin Chem
Clin Biochem 1989; 27:157—62). The method comparisons (n = 55) for the new combined method presented
versus the reference method for creatinine and the candidate reference method for uric acid resulted in coefficients
of correlation of r = 1.000 for both analytes.
The new combined method presented is useful for the analysis of patient samples where the classical photometric
procedures do not give reliable results, as often observed in monitoring after transplantation surgery. The method
presented here is an alternative to less specific photometric procedures with poorer reproducibility previously used
in such cases.
Introduction free of interferences. The determination of uric acid in
serum is much less sensitive to interferences than the
Creatinine and uric acid are two of the most often mea-
 determination of creatinine.
sured clinical-chemical analytes. For the determination
of creatinine, the unspecific Jaffe-method (2), although The aim of this study was to develop a combined
subject to perturbation by many interfering substances method for the determination of both creatinine and uric
from endogenous and exogenous origin, has remained acid, based on high performance liquid chromatography,
popular. More specific enzymatic determination meth- which should be as matrix independent as possible, im-
ods for creatinine have been developed (3—4), but due precision and inaccuracy should be below 1% and the
to the complexity of th^ir reaction path ways they are not method should be suitable for patient samples. When
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photometric methods do not yield plausible results or
when creatinine monitoring is critical - for example in
transplantation surgery - the use of a HPLC method
is justified instead of photometric methods (i.z.Jaffe's
method) after adsorption to Fuller's earth or the determi-
nation of a sample blank after enzymatic creatinine-de-
gradation are performed (5). In order to test inaccuracy,
NIST-SRM-909 human serum control material was
used, additionally method comparisons were performed
with n = 5 pooled serum specimens and n = 50 indivi-
dual serums specimens. As a comparison method for
creatinine a reference method, an isotope dilution-gas
chromatography-mass spectrometry (ID-GC-MS) with
[13C, 15N2]creatinine as internal standard was used, for
uric acid a candidate reference HPLC method (1) was
choosen.
Materials and Methods
Chemicals
The uric acid (purity 99.7% ± 0.1%) and creatinine (purity 99.8%
± 0.1%) used for preparation of the standard solutions were Stan-
dard Reference Materials (SRM913 resp. SRM914a) from the Na-
tional Institute of Standards and Technology, Washington D. C.
20234, U. S.), [I3C, I5C2]creatinine used as internal standard in ID-
GC-MS-measurements was a generous gift of Dr. Kobold, Boeh-
ringer Mannheim GmbH, Werk Tutzing, N-Methyl-N-trimethyl-
silyltrifluoroacetamide as well as pyridine (Silylation Grade
Solvent) was supplied by Macherey & Nagel (D ren, Germany),
creatinine-imidohydrolase and uricase were from Boehringer
Mannheim (Mannheim, Germany), all other chemicals were of ana-
lytical grade and purchased from Merck (Darmstadt, Germany),
SIGMA (Munich, Germany) and from Baker (Gro -Gerau, Ger-
many). Bakerbond SPE-solid phase extraction cartridges were from
Baker (Gro -Gerau, Germany). Deionized water was prepared with
a Milli-Q apparatus (Millipore GmbH, Eschborn, Germany).
Samples
The control material used for checking inaccuracy of the methods
was Human Serum SRM 909 from the National Institute of Stan-
dards and Technology, Washington D. C. 20234, U. S.). The other
control materials were Precinorm U (Chargen-Nr. 16915101) and
Precipath U (Chargen-Nr. 16913801) from Boehringer Mannheim
GmbH (Mannheim, Germany).
For the recovery experiments 5 pools were prepared from patient
sera. For the method comparisons 50 patient samples, 20 in the
normal range and 30 in the pathological range, were used. All spec-
imens were collected in Sarstedt-Monovettes with separation-gel.
After centrifugation serum was obtained.
Instruments and settings
New combined high performance liquid chromatography
The HPLC was performed on a Bruker LC-21 Chromatographie
system with a LC-51 autoinjector and a tuneable Gynkotec 4-wave-
length detector Model tuned at 232 nm for the detection of creati-
nine and 292 nm for the detection of uric acid. System controlling
data acquisition, integration and calibration was performed with
Bruker Chromstar V3.20, the absorbance data at 232 nm and 292
nm were acquired simultaneously.
For the candidate HPLC-method for uric acid the Chromatographie
conditions were as described in I.e. (1), for the new combined
HPLC-method presented here, the simultaneous determination of
uric acid and creatinine, a μBondapak CIS (10 μηι particle-size),
300 mm X 3.9 mm analytical column (Waters Chromatographie,
Eschborn, Germany) with μBondapak CIS precolumn insert was
used. The eluent buffer A consisted of 27.f5 mmol/1 sodium dihy-
drogenphosphate, 2.5 mmol/1 octanesulptionic acid, pH 4.2, aceto-
nitrile, volume fraction 0.1, column purging was performed with
eluent buffer B consisting of 2.5 mmol/1 sodium dihydrogenphos-
phate, 2.5 mmol/1 octanesulphonic acid, acetonitrile, volume frac-
tions 0.60. The pH of buffer B was set to 4.2 by adding concen-
trated NaOH. The flow-rate was 1 ml/min. The injection volume
was 50 μΐ for all samples. The duration of one chromatography
was 8 min. Every 15 chromatographies the column was purged
with Buffer B for 5 min and the column was then equilibrated with
Buffer A for 35 min.
Candidate reference high performance liquid chromatography for
uric acid
The candidate reference HPLC was performed identically as de-
scribed before (1).
Isotope dilution-gas chromatography-mass spectrometry of creati-
nine
The instrument used was a Finnigan 1020 combined gas-chromato-
graph quadrupole-mass-spectrometer with Perkin-Elmer Sigma 3
gas-chromatograph, equipped with a Permabond FS-SE-52, 0.2*5
μπα, 25 m X 0.32 mm ID capillary column (Macherey & Nagel,
D ren, Germany).
GD-conditions: The carrier gas was helium at 70 kPa inlet pressure,
the split^exit was set at 30 ml/min, the injector temperature was
190 °C, the oven temperature was isothermal 170 °C, the transfer
line has heated to 190°C. The retention-time of the creatinine-
derivative was 3.5 min.
MS-conditions: El-Modus (70eV), selected mass detection at m/e
= 329 ± 0.25 (creatinine) and m/e = 332 ± 0.25 ([13C, l5C2]crea-
tinine), 0.28 seconds per scan and 0.14 seconds scantime per mass.
Procedures and measurements
Weighing procedures
Uric acid (SRM 913), creatinine (SRM 914) and the isotopicaliy
labelled creatinine were weighed on a micro balance (Mikrowaage
708501, Fa. Sartorius, G ttingen, Germany). All other weighing
procedures, including all required calibrations of volumetric de-
vices, were done on a semimicro balance (Halbmikrowaage 2004
MP, Fa. Sartorius, G ttingen, Germany).
Preparation of stock standards and reconstitution of control sera
The reconstitution of lyophilized control sera as well as the prepa-
ration of the uric acid standards was performed as previously de-
scribed (1), giving a stock standard concentration for uric acid of
357 μηιοΐ/ΐ. The uric acid stock standard was freshly prepared ev-
ery day. Creatinine stock-standards were prepared by dissolving
the weighed SRM 914 - 2.3 mg for HPLC, 1.5 mg for ID-GC-MS
- in 100 ml, giving a stock standard concentration for creatinine of
203 μηιοΐ/ΐ for HPLC-measurenients and a stock standard concen-
tration for creatinine of 133 μηιοΐ/ΐ for ID-GC-MS-measurements.
The creatinine stock standard was stable for at least one week at
4 °C. As internal standard for the ID-GC-MS 3 mg of the isotopi-
caliy labelled creatinine were dissolved in 25 ml HPLC-water, giv-
ing a stock standard concentration for the internal standard of 1061
μηιοΐ/ΐ. This internal standard was prepared once, and aliquots of
1 ml were freezed at -70 °C. · *
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Serum dilutions
All sera, control sera, patient sera and serum pools were diluted
with a gravimetrically calibrated Microlab 1000 (Fa. Hamilton,
Darmstadt, Germany). The diluted serum samples were filtered
through membrane filtration devices with a pore diameter of 0.2
μπι (Sartorius GmbH, G ttingen, Germany).
Measurements with the new combined HPLC
For the new combined HPLC-method presented here, the standards
used for calibration contained both analytes. The calibration stan-
dards were prepared freshly every day with the Microlab 1000 sys-
tem. Equal amounts of the stock standard solutions of creatinine
and uric acid were mixed and diluted with elution buffer A to give
standards with 0.05cslock, 0.1 c^o«*, and 0.15cslock for creatinine as
well as uric acid, giving the following final concentrations (in
μπκ>1/1) for uric acid/creatinine: 53.4/30.45, 35.6/20.3, 17.8/10.15.
The calibration range was therefore 17.8—53.4 μπιοΐ/ΐ for uric acid
and 10.15-30.45 μιηοΐ/ΐ for creatinine. For all serum samples the
dilution 1:10 was measured first. Measurements with an area re-
sponse out of the calibrated concentration-range were rechromato-
graphed in an appropriate second dilution which in our study for
the most cases was a dilution of 1 : 20. Only 7 sera with creatinine
concentration above 600 μπιοΐ/ΐ required a 1 : 30 dilution for the
determination of creatinine, in the case of serum concentrations
below 50 μιηοΐ/ΐ and/or uric acid serum concentrations below 178
μπιοΐ/ΐ the serum dilution 1 : 5 was chromatographed. All serum,
SRM 909 and standard samples were prepared twice. The measur-
ing sequence in this study was as follows: low standard in tripli-
cate, medium standard in triplicate, high standard in triplicate,
SRM 909 in triplicate, 5 serum samples in triplicate, SRM 909 in
triplicate, 5 serum samples in triplicate. Then in the second run the
procedure was repeated with the second dilution of all standards,
the SRM 909 and the 10 sera.
Calibration and calculation for the new combined HPLC
For the new method, the calibrations for creatinine as well as uric
acid were based on peak areas; linear concentration peak-area-rela-
tionships were used for both analytes, whereby the calibration
curves showed neither an intercept significantly deviating from the
origin nor a significant non-linearity.
Measurements with the candidate reference HPLC for uric acid
All serum samples were treated in this case like the reconstituted
control sera in that study (1).
/fror the first pipetting step, it is necessary to fit individually the
aliquot of each serum sample to a constant amount of internal stan-
dard to give an isotope ratio (unlabelled/labelled) in the final ID-
GC-MS measurement between 0.9 and 1.1. Therefore 50 μΐ of the
internal standard were added to an anliquot of serum (typically
between 100—600 μΐ), which contained about 6 μg creatinine. This
is the most critical volumetry in the ID-GC-MS procedure and has
to be performed very exactly. Then 0.1 mol/1 HC1 with an amount
of half of the volume of the serum aliquot was added and finally
HPLC-water was added to give a final volume of 1 ml. This sample
was mixed and equilibrated for 2 h. Next a solid-phase extraction
of the sample was performed on Bakerbond SPE-columns, which
were previously conditioned with 3 ml methanol and 3 ml HPLC-
water. After washing the column with 3 ml water, the creatinine
was extracted from the columns with 4 ml eluent-buffer (6.5 mmol/
1 Na2HPO4, 2.5 mmol/1 NaH2PO4, 150 mmol/1 NH4CO3, pH 8.0),
the first 2 ml of the column-eluate was discarded. The 2 ml eluate
was evaporated under a nitrogen-stream at 60 °C to dryness, the
residue was further processed as described for the evaporated stan-
dard samples. From each standard, control serum and patient se-
rum, two samples were prepared for ID-GC-MS and each sample
was chromatographed in triplicate.
Calibration and calculation for the candidate reference HPLC for
uric acid
For the GC-MS measurements 1.5 μΐ were injected, and peak-in-
tegration was performed with the Finnigan-1020 Software. Subse-
quent calculations were performed using the procedure described
by Siekmann (6).
Results
Specificity
The chromatogram of a uric acid/creatinine-standard is
shown in figure la, the chromatogram of a control se-
rum is shown in figure Ib and that of a patient serum
sample in figure Ic. For the patient serum a much more
complicated matrix compared to the control material is
evident in the chromatogram at 232 nm. After enzymatic
treatment with creatinine-imidohydrolase and uricase in-
terfering substances underlying the peaks of the analytes
could not be detected in the samples used in this study.
Calibration and calculation for the candidate reference HPLC for
uric acid
For the candidate reference HPLC for uric acid, a calibration
method previously published (1) was used.
Measurements with the ID-GC-MS for creatinine
Internal standard (50 μΐ) were added to 300 μΐ (Standard A), 400
μΐ (Standard B), 500 μΐ (Standard C) creatinine-stock-standard with
a Microlab 1000 (Hamilton, Darmstadt, Germany), HPLC-water
was added to give a final volume of 1 ml, then the standards were
evaporated at 60 °C under a stream of nitrogen to dryness. For the
determination of the isotope-ratio of the unlabelied standard and
the labelled internal standard, 400 μΐ of the stock standard or 50 μΐ
of the internal standard (both containing about 6 μg creatinine)
were were evaporated directly. Fifty μΐ of 1 : 1 (v : v) mixture of N-
methyl-N-trimethylsilyltrifluoracetamide and pyridine (dried over
molecular sieve) was added to the dried residue and the derivatisa-
tion was performed for 40 min at 60 °C.
Imprecision
The imprecision of the Chromatographie method and the
applied peak integration procedure was determined from
the areas obtained for the triplicate measurements of the
samples. This imprecision was less than 0.2% for the
standards, less than 0.3% for SRM 909 and less than
0.6% for the serum samples. The deviations between
two different dilutions never exceeded 0.4% for all sam-
ples measured in this study.
The within-run imprecision has been calculated for the
means of the triplicates of three standard samples and
five serum-pools from n = 10 runs and was for both
analytes less or equal than 0.5% (CV) in the case of
standards and less or equal than 0.8% (CV) in the case
of pool sera (tab. la). The day-to-day imprecision has
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Fig. la Chromatogram obtained with the new combined HPLC
method for a standard mixture of 1 nmol creatinine and 1.8 nmol
uric acid performed with UV absorbance detection at 232 nm and
292 nm.
Peak identification: 1. creatinine; 2. uric acid
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Fig. Ib Chromatogram obtained with the new combined HPLC
method for a sample of a control serum (SRM 909), performed
with UV absorbance detection of 232 nm and 292 nm. Injected
were 50 μΐ of a 1 : 10 diluted serum sample, giving an amount of
0.75 nmol creatinine and 2.4 nmol uric acid.
Peak identification: 1. creatinine; 2. uric acid
Tab. la Within-run imprecision for the method for the simulta-
neous determination of uric acid and creatinine, calculated for three
aqueous standards and five human pool sera from η = 10 runs.
For the determination of creatinine Standard 1 and Pool 1 were
measured in a 1 : 5 dilution, Standard 2 and Pool 2—4 were mea-
sured in a 1 : 10 dilution, Standard 3 and Pool 5 were measured in
a 1 : 20 dilution.
For the determination of uric acid, Standard 1-2 and Pool 1-4
were measured in a 1 : 10 dilution, Standard 3 and Pool 5 were
measured in a 1 : 20 dilution.
Creatinine in μηιοΐ/ΐ
Standard
1 2 3
x 100.0 200.0 299.8
± s 0.5 0.7 1.6
CV(%) 0.5 0.4 0.5
Pool
1 2 3 4
62.5 109.7 153.1 182.8
0.5 0.8 0.9 1.3
0.8 0.7 0.6 0.7
5
400.4
3.4
0.8
Uric acid in μιηοΐ/ΐ
Standard
1 2 3
x 198.8 498.3 800.3
± s 0.8 1.5 1.7
CV(%) 0.4 0.3 0.2
Pool
1 2 3 4
243.7 420.7 483.6 338.8
1.8 2.7 2.4 1.3
0.7 0.6 0.5 0.4
5
736.8
4.4
0.6
CV = Coefficient of variation in %
been calculated for aliquots of the five serum-pools at
η = 10 different days; the aliquots of the pools have
been stored at —70 °C and were equilibrated at room
temperature before processing after thawing. Only the
pool-sera in the normal-range (Pool 1 and 2) show a CV
of 1.1% in the case of creatinine, all other imprecisions
determined for both analytes were less or equal than
1.0% (tab. Ib). Table 2 shows the imprecisions for the
same serum pools obtained for creatinine by ID-GC-MS.
Inaccuracy
Table 3 shows the recoveries, of added uric acid and
creatinine standards to a pool serum. Only in one case
for the creatinine determination was the deviation
-0.7% with an CV of 0.5%, for all other recoveries the
deviations from 100% were less than the CV for both
analytes. For the determination of creatinine by ID-GC-
MS all recoveries determined had a deviation from
100% less than the CV.
The inacpuracy of the HPLC-method for the simulta-
neous determination of uric acid and creatinine was
checked with the control material.SRM-909. The coeffi-
cient of variation for this control material, obtained from
Eur J Clin Chem Clin Biochem 1995; 33 (No 1)
Kock et al.: Simultaneous determination of creatinine and uric acid by HPLC 27
600
— 500
£
Φ 400
£ 300
= 200
100
ο
/Tab. 2 Day to day imprecision of the ID-GC-MS-method for the
determination of creatinine, calculated for five human pool sera
j[ from η = 10 runs.JJ For the determination of creatinine, Pool 1 was measured in a 1 : 5dilution, Pool 2—4 were measured in a 1 : 10 dilution, Pool 5 wasmeasured in a 1 : 20 dilution.Creatinine in μηιοΐ/ΐΛ β Pool 1 2 3 4 5v\ Η ΛΛ ΑW J\J V A . χ 59.5 110.2 151.6 182.4 399.3
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Fig. Ic Chromatogram obtained with the new combined HPLC
method for a sample of a patient serum, performed with UV absor-
bance detection at 232 nm and 292 nm. Injected were 50 μΐ of a
1 : 10 diluted serum sample, giving an amount of 0.6 nmol creati-
nine and 2.0 nmol uric acid.
Peak identification: 1. creatinine; 2. uric acid
Tab. 3 Recovery of the method for the simultaneous determina-
tion of creatinine and uric acid, calculated for Pool 1, spiked with
uric acid or creatinine-standard.
For creatinine, the serum samples spiked with 50.04—200.14
μπιοΐ/ΐ were measured in a 1 : 10 dilution, the sample spiked with
300.17 μηιοΐ/ΐ was measured in a 1 : 20 dilution.
For uric acid, the serum samples spiked with 100.03—200.06
μπιοΐ/ΐ were measured in a 1 : 10 dilution, the samples spiked with
400.12-600.18 μπιοΐ/ΐ were measured in a 1 : 20 dilution.
Addition of
creatinine
[μηιοΐ/ΐ]
50.04
100.07
200.14
300.21
Recovery
[%]
100.1 ±0.7
99.5 ± 0.7
99.3 ± 0.5
100.4 ± 0.8
Addition of
uric acid
[μηηοΐ/ΐ]
100.03
200.06
400.12
600.18
Recovery
[%]
100.4 ±0.7
100.2 ±0.8
99.8 ± 0.6
100.6 ±0.7
Tab. Ib Day to day imprecision for the method for the simulta-
neous determination of uric acid and creatinine, calculated for five
human pool sera from η = 10 runs.
For the determination of creatinine, Pool 1 was measured in a 1 : 5
dilution, Pool 2—4 were measured in a 1 :10 dilution, Pool 5 was
measured in a 1 : 20 dilution.
For the determination of uric acid, Pool 1 -4 were measured in a
1:10 dilution, Pool 5 was measured in a 1 : 20 dilution.
Creatinine in μιηοΐ/ΐ
X
± s
CV (%)
χ ± s
CV (%)
Pool 1
61.3
0.7
1.1
Uric acid
Pool 1
245.0
1.4
1.0
2
108.7
1.2
1.1
in umol/l
2
421.8
3.2
0.8
3
152.8
1.2
0.8
3
482.3
3.7
0.8
4
181.7
1.5
0.8
4
340.3
2.5
0.7
5
396.3
3.7
0.9
5
734.2
4.9
0.7
CV = Coefficient of variation in %
n = 10 determinations (performed on separate days),
was 0.8% for creatinine as well as for uric acid, for both
analytes the mean value from these n = 10 determin-
ations deviated +0.5% from the certified value.
For the method comparison the mean values (n = 6) for
the serum samples were used, obtained from the two
dilutions or ID-GC-MS sample preparations, each chro-
matographed in triplicate. For the 5 pool sera and 50
patient samples, the mean results for the method pre-
sented here were compared to the mean results of the
candidate reference HPLC-method for the determination
of uric acid (fig. 2a) and the reference ID-GC-MS-
method for the determination of creatinine (fig. 2b). The
method comparison with the procedure of Bablok and
Passing yielded the following relationships:
For uric acid (concentration range of the reference
method 143 μηιοΙ/1-1339 μτηοΐ/ΐ) Curic acid (combined
method) = 1-002 X Curic acjd (reference HPLC) ~~ 0.356 μΠ1θ1/1
confidence interval
for slope b:
confidence interval
for intercept a:
coefficient of
correlation r:
0.989 1.015
-4.29 μιηοΐ/ΐ - +4.22 μηιοΐ/ΐ
1.000
For creatinine (concentration range of the reference
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Fig. 2a Correlation of the analytical results for the means of the
uric acid determination in n = 55 serum samples with the new
combined HPLC method and the candidate reference HPLC
method.
1000
200 400 600 800
Creatinine(reference |D.GC.Ms) tMmol/l]
1000
Fig. 2b Correlation of the analytical results for the means of cre-
atinine determination in n = 55 serum samples with the new com-
bined HPLC method and the reference ID-GC-MS method.
method 44 μιηοΐ/ΐ -783 μιποΐ/ΐ) Curic acid (combined method)
1.011 X Curic acid (reference ID-GC-MS) ~ 0.280 μΐΤ\θ1/1
confidence interval
for slope b:
confidence interval
for intercept a:
coefficient of
correlation r:
0.993 - 1.014
-1.31 μπιοΐ/ΐ - +0.72 μιηοΐ/ΐ
1.000
Tab. 4 Summary of the data for the calculated deviations be-
tween the presented combined method for the simultanous determi-
nation of creatinine and uric acid and the chosen reference methods
Determination of creatinine
Determination of uric acid
Fraction of
samples
• I
96%
62%
29%
98%
47%
Deviation
between
methods
<3.6%
<2.0%
<1.0%
<2.5%
<1.0%
The statistics for the deviations between the results ob-
tained with the combined method and the reference
methods are summarized in table 4.
Conclusions
The aim of this study was the evaluation of a high-per-
formance liquid chromatography for the simultaneous
determination of creatinine and uric acid in serum. The
imprecision was less or equal than 1.1% for both ana-
lytes, and it was below 1% for control material; the ina&·
curacy in the standard recovery experiments was even
lower. The imprecision data from the triplicate chroma-
tographies of the samples suggest that only one mea-
surement of each serum dilution for all samples is re-
quired. The method was tested against a reference
method for the determination of creatinine (7) and a can-
didate reference method for the determination of uric
acid (1). For η = 55 human serum samples we found
very good correlations between the results for both ana-
lytes obtained with the combined method and the meth-
ods choosen as reference. Ninety-six percent of the sam-
ples had a difference of the analytical results for creati-
nine between the method presented and the ID-GC-MS-
method less than or equal to 3.6%. In the case of uric
acid, 98% of the samples showed a difference less than
or equal to 2.5%. For uric acid the results are compara-
ble to those for control materials and in the case of creat-
inine it is expected that due to the simpler matrix of
those control materials the observable deviations should
be even less than those found for patient samples.
Recently, several methods for the determinations of cre-
atinine have been published, mostly based on cation-
exchange-HPLC (8-11). Rosano et al. proposed a
method based on this principle as a reference method
(12) and Linnet et al. proposed a candidate reference
method where a sample preparation procedure with cat-
ion-exchange chromatography is followed by reversed-
phase-HPLC and enzymatical quantification (13). The
principle of ion-pair-gradient HPLC of serum-ultrafil-
trates has also been utilized for the development of can-
didate reference methods (14). »
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For the separation of uric acid and creatinine, the most
suited separation system was the ion-pair reversed-phase
chromatography, where an added ionic modifier, in this
method octanesulphonic acid, will react under certain
conditions with cationic serum components to yield ion-
pairs, which will retard the elution by a reversed-phase
stationary phase. This principle has been previously
used for the HPLC of creatinine, but all methods de-
scribed may introduce additional sources of imprecision
and inaccuracy due to their complex sample preparation;
a direct injection of a diluted and filtered serum or con-
trol material can minimize these analytical problems.
The data obtained for day-to-day imprecisions as well
as those for the recoveries show the advantage of the
method presented here. Moreover the method evaluated
in this study does not require a pump with gradient capa-
bilities, the system only needs to be equipped with an
eluent switching device, and further only a one-wave-
length-tuneable UV-detector with wavelength switching
is needed as the simultaneous acquisition at 232 nm and
292 nm is not absolutely required.
The method was primarily developed for clinical
purposes. Here the determination of creatinine is a cru-
cial element of patient surveillance, for example
following transplantation surgery, where the drug-treat-
jhent of the transplanted patients is most complex and
metabolism and pharmacokinetics are often in disorder.
In those cases the spectrophotometrical determination of
creatinine, fully enzymatic or special modifications of
the Jqffe-method do not fit the requirements due to the
often overly complex interferences occuring in the sam-
ples of these patients. The HPLC-method presented will
therefore be of value as an "in lab reference" for the
precise monitoring of the serum-concentration of creati-
nine and uric acid in those cases where the classical
methods are suspected of giving erroneous results and
the determination of these analytes is critical for the
treatment of the patient.
The method presented here is the first high-perfor-
mance-liquid-chromatography for the simultaneous de-
termination of creatinine and uric acid, where a full
method evaluation including a method comparison
against established candidate reference method was per-
formed. The method can be applied in clinical cases
where spectrophotometric methods, which are more un-
specific and more susceptible to interferences, have to
be replaced. Clinical investigations concerned with this
field are in progress and the applicability of the method
for urine is under study.
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